Gayer Charles K - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 22, 2025, Gayer Charles K's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Officer (President and CCO), and currently has 952,583 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BCRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Gayer Charles K - Insider Non-Derivative Transactions of BCRX Common Stock

Gayer Charles K - Insider Non-Derivative Transactions at BCRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 23, 2025	M -- (Common Stock)	14142	3.22	892492
Dec 23, 2025	M -- (Common Stock)	10091	5.04	902583
Dec 23, 2025	M -- (Common Stock)	50000	5.51	952583
Dec 20, 2025	F -- (Common Stock)	11477	7.41	878350
Dec 18, 2025	Acquisition -- (Common Stock)	471000	0	889827
Dec 13, 2025	F -- (Common Stock)	8181	7.57	418827
Dec 20, 2024	F -- (Common Stock)	2461	7.39	423546
Dec 20, 2024	Acquisition -- (Common Stock)	125950	0	426007
Dec 15, 2024	F -- (Common Stock)	8251	7.53	300057
May 14, 2024	P -- (Common Stock)	30000	5.47	307533
Dec 20, 2023	F -- (Common Stock)	2482	6.05	274533
Dec 15, 2023	F -- (Common Stock)	5840	6.43	277015
Dec 15, 2023	Acquisition -- (Common Stock)	34000	0	282855